| Spirig HealthCare AG - Oxycodon Naloxon Spirig HC 5 mg/2.5 mg, Retardtabletten | | 65931 | | 01 | | Oxycodon Naloxon Spirig HC 5 mg/2.5 mg | | Retardtabletten | | N02AA55 | | Oxycodone and Naloxone | | 16.03.2017 | | |
| | Composition | | oxycodoni hydrochloridum 5 mg, naloxoni hydrochloridum anhydricum 2.5 mg ut naloxoni hydrochloridum dihydricum, povidonum K 30, poly(vinylis acetas), povidonum K 27-32, natrii laurilsulfas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, pro compresso obducto corresp. natrium 0.02 mg. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Naloxone Hydrochloride Anhydre | 2.5 mg | | Oxycodon-Hydrochlorid | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Naloxone Hydrochloride Anhydre | 2.5 mg | | Oxycodon-Hydrochlorid | 5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | E 171 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Poly(Vinylis Acetas) | | | | Povidonum K | 27-32 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
